Fewer Functional Deficits and Reduced Cell Death after Ranibizumab Treatment in a Retinal Ischemia Model

Retinal ischemia is an important factor in several eye disorders. To investigate the impact of VEGF inhibitors, as a therapeutic option, we studied these in a retinal ischemia animal model. Therefore, animals received bevacizumab or ranibizumab intravitreally one day after ischemia induction. Via el...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmhof, Marina, Lohmann, Stephanie, Schulte, Dustin, Stute, Gesa, Wagner, Natalie, Dick, H. Burkhard, Joachim, Stephanie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032266/
https://www.ncbi.nlm.nih.gov/pubmed/29857531
http://dx.doi.org/10.3390/ijms19061636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032266/
https://www.ncbi.nlm.nih.gov/pubmed/29857531
http://dx.doi.org/10.3390/ijms19061636

Ejemplares similares